|
|
|
|
|
by urinotherapist
1066 days ago
|
|
> First of all, there were many jumps of SARS from animals into humans, over a period of months in which the markets containing infected animals were open. Can you point me to one or two cases you are talking about, please? |
|
Note that no comparable data associates SARS-CoV2 with the lab in Wuhan.
[0] The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic https://www.science.org/doi/full/10.1126/science.abp8715
>we inferred separate introductions of SARS-CoV-2 lineages A and B into humans from likely infected animals at the Huanan market (38). We estimated the first COVID-19 case to have occurred in November 2019, with few human cases and hospitalizations occurring through mid-December. [...] the evidence presented here that lineage A, like lineage B, may have originated at the Huanan market and then spread from this epicenter into the neighborhoods surrounding the market and beyond.
Edit: Additional study:
[1] The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 https://www.science.org/doi/10.1126/science.abp8337
>We show that SARS-CoV-2 genomic diversity before February 2020 likely comprised only two distinct viral lineages, denoted “A” and “B.” Phylodynamic rooting methods, coupled with epidemic simulations, reveal that these lineages were the result of at least two separate cross-species transmission events into humans. The first zoonotic transmission likely involved lineage B viruses around 18 November 2019 (23 October to 8 December), and the separate introduction of lineage A likely occurred within weeks of this event.